Our Director of Patient Services, Julie White, RN, BSN, OCN, sits down with Michael Offin, MD, an oncologist and mesothelioma specialist at Memorial Sloan Kettering Cancer Center. They are discussing the current clinical trial “A Phase 1a/1b Basket Trial of BMS-986504 with Standard-of-Care Therapy For Patients with Metastatic MTAP-deleted Solid Tumors” offered at Memorial Sloan Kettering Cancer Center.
If you have any questions about clinical trials and if this trial could work for you or your loved one, please reach out to our Director of Patient Services, Julie White, at [email protected].
Our Sponsors
MesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made possible by our generous sponsors: Belluck Law, Dean Omar Branham Shirley, LLP; Maune Raichle Hartley French & Mudd, LLC (MRHFM); The Gori Law Firm; Merck; Early Luccarelli Sweeney & Meisenkothen, LLC; AstraZeneca
Search our previous episodes for topics/speakers of interest to you at www.curemeso.org/mesotv
